NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 3Y Ago
0x
Contraction
Streak
4 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -6.32% |
| 2024 | -5.03% |
| 2023 | 83.79% |
| 2022 | 199.39% |
| 2021 | 486.36% |
| 2020 | 0.00% |